Ublituximab (Anti-CD20)Ublituximab (Anti-CD20)
Move your mouse over image or click to enlarge

Ublituximab (Anti-CD20)

Ublituximab (Anti-CD20) is a chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity. MW : 145.22 KD.
Cat# Size Price Qty Buy
A2807-1mg*25 1mg*25
£2,432.00
A2807-1mg*5 1mg*5
£794.00
A2807-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2807

Related Documents